Prevention of equine herpesvirus myeloencephalopathy - Is heparin a novel option? A case report.

Tierarztl Prax Ausg G Grosstiere Nutztiere

Dr. Jasmin Walter, Klinik für Reproduktionsmedizin, Vetsuisse-Fakultät der Universität Zürich, Winterthurerstrasse 260, 8057 Zürich, Schweiz, E-Mail:

Published: October 2016

AI Article Synopsis

  • Equine herpesvirus myeloencephalopathy (EHM) is a serious condition resulting from equine herpesvirus 1 (EHV-1), and effective prevention and treatment options are currently lacking.
  • A study was conducted during an EHV-1 outbreak where 31 febrile horses received heparin treatment, while 30 febrile horses did not.
  • Results showed that heparin-treated horses had a significantly lower incidence of EHM (3.2%) compared to untreated horses (23.3%), suggesting heparin could be beneficial, but further randomized studies are needed.

Article Abstract

Equine herpesvirus myeloencephalopathy (EHM) is a severe manifestation of equine herpesvirus 1 (EHV-1) infection. Prevention and treatment of EHM during EHV-1 outbreaks is critical, but no reliable and tested specific medication is available. Due to the thromboischemic nature of EHM and due to the fact that EHV-1 entry in cells is blocked by heparin, it was hypothesized that this compound may be useful in reduction of EHM incidence and severity. Therefore, during an acute EHV-1 outbreak with the neuropathogenic G/D Pol variant, metaphylactic treatment with heparin to prevent EHM was initiated. Clinical signs were present in 61 horses (fever n = 55; EHM n = 8; abortion n = 6). Heparin (25000 IU subcutaneously twice daily for 3 days) was given to 31 febrile horses from day 10 of the outbreak, while the first 30 horses exhibiting fever remained untreated. Treatment outcome was analyzed retrospectively. Heparin-treated horses showed a lower EHM incidence (1/31; 3.2%) than untreated horses (7/30; 23.3%; p = 0.03). Results indicate that heparin may be useful for prevention of EHM during an EHV-1 outbreak. These promising data highlight the need for randomized and possibly blinded studies for the use of heparin in EHV-1 outbreaks.

Download full-text PDF

Source
http://dx.doi.org/10.15653/TPG-150451DOI Listing

Publication Analysis

Top Keywords

equine herpesvirus
12
herpesvirus myeloencephalopathy
8
ehm
8
ehm ehv-1
8
ehv-1 outbreaks
8
ehm incidence
8
ehv-1 outbreak
8
heparin
6
ehv-1
6
horses
5

Similar Publications

Effect of thymidine kinase-deficiency (∆ORF38) on neuropathogenicity of equine herpesvirus-1 in the mouse model and expression of neighboring genes.

Virus Genes

December 2024

Laboratory of Veterinary Microbiology, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.

Previous studies showed that deletion of the viral thymidine kinase (TK) gene in several alphaherpesviruses including EHV-1 reduced their virulence. Previously, we found that deletion of ORF37, which is located head-to-head with TK, decreased EHV-1 virulence in mice but did not affect the expression of TK mRNA. Therefore, deletion of ORF38 might also affect virulence by partially deleting the ORF37 promoter.

View Article and Find Full Text PDF

Respiratory disorders (RDs) are a common transport-related welfare consequence in horses. This prospective study described the journeys of horses transported to two slaughterhouses in Italy, documented the prevalence of potentially RD-related pathogens, and identified possible predisposing factors. Data were recorded from arrival until 48 h after arrival and included the collection of Deep Nasopharyngeal Swabs (DNS), journey details and welfare assessment of horses (n = 155).

View Article and Find Full Text PDF

Generalized sarcoidosis associated with hypertrophic osteopathy in a Standardbred racehorse.

J Equine Vet Sci

November 2024

Department of Functional Sciences, Equine Division, Sports Medicine Section, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium. Electronic address:

A Standardbred racehorse was presented for exercise intolerance, weight loss, pyrexia and facial deformity. Radiography and ultrasonography revealed periostitis and regional soft tissue swelling of maxillary bones. Computed tomography excluded any dental or sinus origin of these abnormalities.

View Article and Find Full Text PDF

Equid herpesvirus type 8 (EqHV-8) is known to cause respiratory disease and miscarriage in horses and donkeys, which is a major problem for the equine farming industry. However, there are currently limited vaccines or drugs available to effectively treat EqHV-8 infection. Therefore, it is crucial to develop new antiviral approaches to prevent potential pandemics caused by EqHV-8.

View Article and Find Full Text PDF

Characterization of Nasal Mucosal T Cells in Horses and Their Response to Equine Herpesvirus Type 1.

Viruses

September 2024

Department of Population Medicine and Diagnostic Science, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.

Article Synopsis
  • Equine herpesvirus type 1 (EHV-1) enters horses through the upper respiratory tract, where mucosal immunity plays a key role in fighting the virus.
  • A study collected intranasal immune cells from horses during EHV-1 infection, finding that CD4 and CD8 T cells increased significantly after the infection.
  • Researchers identified distinct roles for these T cells in healthy horses and during infection, revealing specific patterns of accumulation in nasal tissue and a lack of response from mucosal T cells to EHV-1 upon re-stimulation.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!